Categories: BioTechFinTechFirmFoodTechGovTechHealthTechInvestmentProductScienceTechnology
Prota Therapeutics is an Australian, proprietary limited, privately-held biotech company established in 2016 to develop and commercialize novel oral immunotherapy treatments. Prota holds an exclusive license to the proprietary food immunotherapy technology, developed at the MCRI. Series A funding of AUD $15m was secured from OneVentures, a leading Australian venture capital investment firm (OneVentures’ Healthcare Fund III) – including $5M from the Australian Commonwealth Government Biomedical Translation Fund – as well as private investment. This has enabled Prota to advance it’s clinical program, develop scalable cGMP product manufacturing processes, and initiate discussions with regulatory agencies in the lead up to a planned large-scale pivotal Phase 3 efficacy and safety study for the PRT120 peanut allergy treatment.
Prota Therapeutics has its headquarters in Melbourne, Australia.
New York
545 West 25th Street, 20th Floor New York, NY, USA 10001
Singapore
79 Science Park Drive, Level 06 Unit 01/08, CINTECH IV, Science Park 1 Singapore 118264
Investors 1
Funding Rounds 1
Mentions in press and media 8
| Date | Title | Description | Source |
| 29.04.2024 | Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne N... | MELBOURNE, Australia, April 29, 2024 /PRNewswire/ -- Prota Therapeutics' CEO Professor Mimi Tang has... | en.prnasia... |
| 26.04.2024 | Ten startup raises worth getting excited about in 2024 | Femtek founder and CEO Olivia Orchowski. Source: Supplied article-article-body
At SmartCompany, we k... | smartcompa... |
| 18.01.2024 | Deals in brief: EDBI invests in AlphaSense, Blue Earth Capit... | Singapore’s EDBI invests in AlphaSense’s Series E round
AlphaSense, a market intelligence and search... | kr-asia.co... |
| 17.01.2024 | Deals in brief: Meals In Minutes, Meiro, and Prota Therapeut... | Meals In Minutes secures USD 1.5 million in 500 Global-led round
Meals In Minutes, a Malaysia-based ... | kr-asia.co... |
| 17.01.2024 | Prota Therapeutics Raises US $21M in Equity and Debt Financi... | Prota Therapeutics, a Melbourne, Australia-based biotechnology company focused on the development of... | finsmes.co... |
| 16.01.2024 | Prota Therapeutics US $21 Million Financing Led by SPRIM Glo... | Financing advances development of Prota’s peanut allergy remission therapy in preparation for a Phas... | sprim.net/... |
| 09.02.2022 | Prota Therapeutics Achieves Peanut Allergy Treatment Milesto... | Groundbreaking New Clinical Trial Data Published in The Lancet Child & Adolescent Health
Data sh... | en.prnasia... |
| - | Prota Therapeutics | “Prota Therapeutics | Developing a novel approach to allergen immunotherapy” | fastfounde... |
Reviews 0
